Pershing Square Reveals 6 Picks For Allergan Board

Pershing Square Capital Management LP, which is partnering with Valeant Pharmaceuticals International Inc. on a $53 billion takeover bid of Allergan Inc., announced Monday a slate of six proposed directors it...

Already a subscriber? Click here to view full article